Zydus receives final approval for Carbidopa tablets

From USFDA

Zydus Cadila has received the final approval from the USFDA to market Carbidopa Tablets, 25 mg. The tablet is used with a combination levodopa/carbidopa product to treat symptoms of Parkinson's disease or Parkinson-like symptoms(such as shakiness, stiffness, difficulty moving). It will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad.

Powered by Capital Market - Live News